Medline (MDLN) Common Equity (2024 - 2026)

Medline (MDLN) posted quarterly Common Equity of $11.3 billion for Q1 2026, down 41.55% quarter-over-quarter from $19.3 billion in Q4 2025.

Medline (MDLN) Common Equity (2024 - 2026) Analysis & Trends

Medline (MDLN) has reported Common Equity for 3 consecutive years, with $11.3 billion the latest figure, recorded in Q1 2026.

In Q1 2026, Common Equity changed N/A year-over-year to $11.3 billion; the TTM figure through Mar 2026 stood at $11.3 billion (changed N/A YoY), while the FY2025 annual figure was $19.3 billion, up 19.36% from the prior year.
Common Equity declined to $11.3 billion in Q1 2026 per MDLN's latest filing, from $19.3 billion in the prior quarter.
Across five years, Common Equity topped out at $19.3 billion in Q4 2025 and bottomed at $11.3 billion in Q1 2026.
Historically, Common Equity has averaged $15.6 billion across 3 years, with a median of $16.2 billion in 2024.
On a YoY basis, Common Equity climbed as much as 19.36% in 2025 and fell as far as 19.36% in 2025.
Medline's Common Equity stood at $16.2 billion in 2024, then grew by 19.36% to $19.3 billion in 2025, then sank by 41.55% to $11.3 billion in 2026.
Business Quant data shows MDLN's Common Equity at $11.3 billion in Q1 2026, $19.3 billion in Q4 2025, and $16.2 billion in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Common Equity (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	18.30 Bn
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	24.42 Bn
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	21.60 Bn
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	6.59 Bn
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	19.08 Bn
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	2.99 Bn
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	4.80 Bn
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	8.24 Bn
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	6.21 Bn
10	Align Technology	11.37 Bn	10.27 Bn	757.43 Mn	4.23 Bn

Download Data